Panic Disorder Treatment | Ketamine for Panic Disorder
A panic attack arrives without warning. One moment you are in a grocery store, or driving, or lying in bed trying to sleep. The next, your heart is pounding, your chest is tight, you cannot get enough air, and some part of your brain has concluded that you are dying right now. It passes. And then you spend the next weeks, months, sometimes years making sure it does not happen again.
That reorganization of your life around avoiding the next attack is where panic disorder takes over. Panic disorder ketamine treatment is one option that some patients with treatment resistant panic disorder eventually consider, and this page explains where it fits, what the evidence supports, and what comes first.
Allay Health and Wellness offers panic disorder ketamine treatment as an off label clinical service in Palm Beach Gardens, Florida, for adults who have not found adequate relief through standard care. This page covers what panic disorder is, why it sometimes resists first line treatment, where panic disorder ketamine treatment fits in the clinical sequence, what the published research shows, and who may be appropriate for evaluation.
What Panic Disorder Actually Is
Panic disorder is defined by recurrent, unexpected panic attacks followed by at least one month of persistent concern about future attacks, worry about the implications of attacks, or significant behavioral changes related to the attacks. Panic attacks are events. Panic disorder is the sustained condition that reorganizes a person’s life around them.
The National Institute of Mental Health identifies panic disorder as a common anxiety condition with significant functional impact, noting that many people also develop agoraphobia, the avoidance of situations where escape might be difficult during an attack.
Panic disorder can also occur alongside major depressive disorder or generalized anxiety disorder, making careful evaluation of overlapping symptoms important. For patients experiencing a broader pattern of persistent anxiety, understanding how ketamine therapy for anxiety may fit within available treatment options can provide useful context. When panic symptoms occur together with treatment resistant depression, the clinical discussion may also include ketamine therapy for depression, with each condition evaluated individually before any treatment recommendation is made.
First Line Treatments for Panic Disorder
Panic disorder ketamine treatment is not where care starts, and any honest clinical resource says so first. First line treatments include CBT adapted for panic with interoceptive exposure and SSRIs or SNRIs. Paroxetine, sertraline, fluoxetine, and venlafaxine are among the most studied. The American Psychological Association maintains clinical guidance on anxiety disorders worth reviewing before any treatment decision.
These treatments work well for a meaningful portion of patients. Panic disorder ketamine treatment enters the clinical conversation for patients who have completed adequate trials of at least two evidence-based approaches without sufficient relief. It is not a shortcut.
Why First Line Treatments Sometimes Fail
When CBT and multiple medication trials have not resolved panic disorder, the clinical picture suggests something about that individual’s neurobiology that standard monoamine targeting approaches have not reached.
Panic disorder involves dysregulated threat appraisal, heightened interoceptive sensitivity, and fear conditioning that maintains avoidance. Standard SSRIs and SNRIs primarily target serotonin and norepinephrine pathways. For patients whose panic circuits are not responding adequately to those mechanisms, a treatment that acts on the glutamate system through a different pathway represents a genuine clinical rationale.
This mechanistic difference is the most defensible basis for considering panic disorder ketamine treatment in treatment resistant presentations. It is not simply trying something new for its own sake. It is targeting a different neurobiological system when the systems that have been targeted have not been sufficient.
Off Label Ketamine for Panic Disorder: The Evidence
Panic disorder ketamine treatment is an off label use. This must be stated precisely at the outset, because it shapes everything that follows.
The FDA has not approved IV ketamine for panic disorder, for any anxiety disorder, or for any psychiatric condition. Ketamine’s only FDA-approved indication is as a general anesthetic. Off label prescribing by a licensed clinician is legal and standard across medicine, but patients deserve to know the regulatory status before evaluation.
Spravato (esketamine) is likewise not approved for panic disorder. Its approval covers treatment resistant depression in adults and depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. Neither indication includes panic disorder, and Spravato is not used at Allay Health and Wellness for panic disorder.
The direct evidence base for panic disorder ketamine treatment is limited. Most published research on ketamine and anxiety has studied anxiety as a secondary outcome in depression trials, or has examined mixed anxiety disorders rather than panic disorder as a specific primary target. A review of ketamine across anxiety and anxiety related disorders published in Frontiers in Psychiatry noted signals of rapid anxiolytic effects but highlighted the need for larger controlled trials specific to individual anxiety diagnoses before definitive conclusions can be drawn.
What makes panic disorder ketamine treatment clinically plausible despite the limited panic specific evidence is the mechanistic argument. Ketamine’s action on NMDA receptors and downstream glutamate pathways may modulate fear conditioning circuits and amygdala reactivity in ways that are relevant to panic disorder, even if those effects have not yet been studied in large panic specific trials. Patients evaluating panic disorder ketamine treatment should understand that this remains a developing area of clinical research.
What Treatment Involves at Allay Health and Wellness
Every patient considering panic disorder ketamine treatment at Allay Health & Wellness begins with an individualized evaluation rather than an automatic treatment recommendation. Our process includes clinical screening, preparation for the infusion experience, ongoing monitoring, and clear aftercare instructions so patients understand what treatment involves before deciding whether to proceed.
Evaluation
The intake for panic disorder ketamine treatment covers your diagnosis, complete treatment history, medications and therapies previously tried with doses and durations, current prescriptions including benzodiazepines, cardiovascular health, substance use history, and current mental health support. No referral is required. Bringing available clinical records can help our team develop a more complete understanding of your treatment history.
Preparation
Preparation receives particular attention for patients with panic disorder because unfamiliar physical or perceptual sensations can sometimes feel activating. Before treatment, we explain what you may experience during an infusion, discuss potential physical effects, and establish practical orienting strategies that can help you understand what is happening throughout the session.
The Treatment Sessions
IV ketamine is administered slowly through an intravenous line in a private, monitored room. A licensed clinician remains present, and vital signs are monitored throughout treatment. Sessions generally last 40 to 60 minutes. When panic disorder ketamine treatment is considered, the number and frequency of infusions are individualized rather than guaranteed. During your evaluation, we explain how ketamine treatment schedules are commonly structured, why the number of sessions can vary, and how clinical response influences decisions about continued treatment.
After Your Session
You may not drive after an IV ketamine session. A responsible adult must arrange transportation home, and you should follow the individualized post-treatment instructions provided by your clinical team.
Panic Disorder and the Interoceptive Challenge
This deserves specific attention for patients with panic disorder, because it differs from how other anxiety presentations interact with the treatment.
Panic disorder is defined in part by catastrophic misinterpretation of bodily sensations. A racing heart, shortness of breath, dizziness, or tingling becomes evidence of imminent danger. The body’s own signals become the primary trigger.
Ketamine produces a dissociative state during infusions: a temporary altered perception of time, space, and self. It also produces transient increases in heart rate and blood pressure and occasionally a floating or detached quality. For patients with panic disorder, these physical sensations can initially mirror the triggers of a panic attack.
This is not a reason to rule out panic disorder ketamine treatment. Many patients with panic disorder complete ketamine infusions without significant difficulty, particularly with adequate preparation. But it is a clinical reality that deserves to be named rather than glossed over. Our preparation process addresses the bodily sensations ketamine produces, frames them in advance, and establishes coping anchors before the first infusion.
Our ketamine assisted therapy in Florida model, which pairs infusions with structured preparation and integration work, is particularly important for panic disorder presentations. A frank account of what infusion sessions physically and experientially involve is what ketamine infusions are really like, and patients with panic disorder considering this treatment are encouraged to read it before their evaluation.
Ketamine as Support for Panic Specific Therapy
The strongest long term intervention for panic disorder is cognitive behavioral therapy with interoceptive exposure. This involves deliberately inducing feared bodily sensations in a controlled therapeutic environment and learning through experience that the sensations are not dangerous. It has strong evidence and produces durable results for many patients.
The clinical challenge is that interoceptive exposure is hard to begin when the anxiety is very severe. Patients who are at peak panic frequency and avoidance may find it difficult to engage with exposure tasks because the threshold of activation is too high for productive learning.
This is one of the most clinically coherent arguments for panic disorder ketamine treatment as a complement to therapy rather than a standalone intervention. If infusions reduce overall anxiety intensity, the feared sensations during exposure exercises may become tolerable enough for the therapeutic work to proceed. Ketamine is not replacing the exposure work. It may be lowering the floor enough for that work to start.
Patients pursuing panic disorder ketamine treatment are encouraged to maintain or establish care with a CBT therapist who has specific experience with panic disorder and interoceptive exposure. This reflects a broader approach in which ketamine therapy fits into a comprehensive mental health plan, supporting coordinated psychiatric and psychotherapeutic care rather than functioning as a substitute for established treatment.
Risks and Side Effects of Panic Disorder Ketamine Treatment
Every patient evaluated for panic disorder ketamine treatment at Allay Health & Wellness receives a clear explanation of potential risks, side effects, and treatment limitations before anything is scheduled. Because IV ketamine for panic disorder is an off label use, informed consent and individualized risk assessment are essential parts of the evaluation.
- Dissociation: Ketamine can cause temporary changes in perception, awareness, time, space, or sense of self. For patients with panic disorder, unfamiliar sensations may feel activating, so we discuss dissociation during preparation and monitor your response throughout every session.
- Heart Rate and Blood Pressure Changes: Temporary increases in heart rate and blood pressure can occur during IV ketamine treatment. Because these physical sensations may resemble symptoms associated with panic, clinical staff monitor vital signs and remain available to explain what you are experiencing.
- Sedation: Ketamine can cause sedation and impaired alertness. You cannot drive after a treatment session, so a responsible adult must provide transportation home.
- Nausea and Dizziness: Some patients experience nausea or dizziness during or after an infusion. These effects are monitored during the post-treatment observation period and generally resolve as the medication’s acute effects subside.
- Psychological Effects: Anxiety, emotional intensity, unusual perceptions, or other psychological effects may occur during treatment. Clinical staff remain present throughout the infusion to monitor your response and provide appropriate support.
- Controlled Substance Considerations: Ketamine is a federally regulated Schedule III controlled substance, so dependency and misuse risk form part of every clinical assessment. Patients concerned about ketamine’s addictive potential can review how dependency risk, supervised use, and substance use history factor into treatment decisions.
No specific outcome from panic disorder ketamine treatment can be predicted or guaranteed. Individual responses vary, and research specific to panic disorder remains more limited than the evidence supporting ketamine for certain other clinical applications. Allay Health & Wellness reviews these limitations alongside your medical and psychiatric history so you can make an informed treatment decision.
Who May Be a Candidate for Treatment
A clinical evaluation is required before any treatment recommendation is made. Adults who may be appropriate candidates for panic disorder ketamine treatment at Allay typically present with the following:
A formal panic disorder diagnosis from a licensed clinician, with documented history of inadequate response to at least two evidence-based treatments at adequate doses and durations. Willingness to maintain or begin engagement with CBT for panic alongside infusion treatment. Absence of medical contraindications including uncontrolled hypertension, unstable cardiovascular conditions, or active psychosis.
Substance use history is evaluated carefully because ketamine is a Schedule III controlled substance. This does not automatically disqualify anyone but is clinically significant in this population, where benzodiazepine use is common. Benzodiazepines interact with ketamine and require specific review during intake.
Allay Health and Wellness treats adult patients 18 years and older exclusively. If you are working through whether panic disorder ketamine treatment makes sense for your situation, our ketamine therapy FAQ addresses common pre-evaluation questions, and who is eligible for ketamine therapy covers the eligibility picture across anxiety presentations.
FAQs about Panic Disorder Ketamine Treatment
Q1. Is ketamine approved for panic disorder?
No. Panic disorder ketamine treatment is an off label use. The FDA has not approved IV ketamine for panic disorder or any psychiatric condition. Spravato® is not approved for panic disorder. CBT, including exposure based approaches, and medications such as SSRIs or SNRIs remain established first line treatments.
Q2. Can a ketamine infusion trigger a panic attack?
Ketamine can produce temporary physical and perceptual changes that some patients with panic disorder may find anxiety provoking. We discuss these effects during evaluation, prepare patients for the treatment experience, and provide clinical monitoring throughout each infusion. Individual experiences vary, and a panic response cannot be predicted.
Q3. How does panic disorder ketamine treatment fit with psychotherapy?
CBT with exposure-based strategies has strong evidence for panic disorder. At Allay Health & Wellness, panic disorder ketamine treatment is not presented as a replacement for established psychotherapy. When ketamine is considered, clinicians evaluate how it may fit within the patient’s broader treatment plan based on individual needs and previous treatment history.
Q4. Does insurance cover panic disorder ketamine treatment?
Off label IV ketamine for panic disorder is generally not covered by most insurance plans. Allay Health & Wellness accepts Medicare, Cigna, UnitedHealthcare, and Aetna for eligible services. We verify available benefits and explain anticipated costs before scheduling treatment. Coverage depends on the individual plan and is never guaranteed.
Q5. What if I currently take benzodiazepines for panic disorder?
Tell our clinical team about all medications you currently take, including benzodiazepines. Your medication regimen and potential interactions will be reviewed during intake. Do not stop, reduce, or otherwise change a prescribed medication unless your prescribing clinician provides appropriate medical guidance.
Q6. Do I need a referral for an evaluation?
No referral is required to request an evaluation at Allay Health & Wellness. Bring information about your diagnosis, previous medications, doses and treatment durations, current prescriptions, and psychotherapy history. This information helps our clinicians determine whether further evaluation for panic disorder ketamine treatment is appropriate.
Schedule a Consultation for Panic Disorder Treatment
If standard treatments for panic disorder have not provided adequate improvement, Allay Health & Wellness offers a clinical evaluation to help determine what options may be appropriate for your individual needs. Our team will review your symptoms, previous treatments, current medications, medical history, and treatment goals before discussing whether panic disorder ketamine treatment has a potential place in your care.
Before scheduling, you can learn more about the clinicians who provide your care, explore the broader mental health conditions we evaluate and treat, and review peer reviewed research that informs our clinical approach. Our team is also available to answer questions about treatment, potential risks, off label use, costs, and what to expect during an evaluation.
Allay Health and Wellness
11000 Prosperity Farms Rd, Suite 101
Palm Beach Gardens, FL 33410
Phone: (561) 421-6444
Email: [email protected]
Allay Health & Wellness exclusively treats adults aged 18 and older. Contact our team when you are ready to schedule a consultation and discuss your options.
Medical Disclaimer: This content is educational only and not a substitute for professional medical advice, diagnosis, or treatment. IV ketamine for panic disorder is an off-label use, not FDA-approved for any anxiety disorder or psychiatric condition. Spravato is not approved for panic disorder. CBT with interoceptive exposure and SSRIs or SNRIs remain recommended first-line treatments. Individual outcomes vary and are never guaranteed. Treatment requires evaluation by a licensed clinician. Allay treats adults 18 and older.
Reviewed by Nicholas Marino, MBA, Co-Founder and CEO, Allay Health and Wellness
